The Abernathy Group II Team Principals
Steven Abernathy, Principal
Steven Abernathy is the founder, principal and chairman of The Abernathy Group II. Prior to founding the Firm, Mr. Abernathy joined Cowen & Co. in 1989 as a special limited partner and director of its Executive Services division. He earned a reputation as a unique professional investor who applied the art of value investing to the Medical and Information Technology sectors of the market. While at Cowen, Mr. Abernathy developed the Collaborative Investing® process, a nationwide network of Medical and Information Technology investors who pool their expertise in order to identify companies with superior products, technologies and management teams. This concept is the foundation of The Abernathy Group's II investment philosophy. Mr. Abernathy attended Fordham University in New York, earning a Bachelor of Science Degree in Biology in 1979.
Brian Luster, Principal
Brian Luster is a Principal and Co-Portfolio Manager of the Abernathy Group II. Mr. Luster joined the firm in 2000 as an equity analyst and has served on the Investment Committee since 2002. During his tenure, he developed “Quantimental Analysis” – a process combining quantitative and fundamental value investing – and Clinical Investing® - a rigorous and systematic catalyst driven investment process focusing on value based fundamental analysis modeled after the FDA's famously stringent drug approval process. These innovations have improved volatility and lowered the overall correlation of portfolios to indices while reducing capital at risk. Mr. Luster has contributed to articles in the American Association of Individual Investors and The Bottom Line. He attended NYU’s Stern School of Business, earning a BS in both Finance and Economics, and has completed post baccalaureate studies in the pre-medical sciences.